Taku Inokuchi
Hyogo College of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Taku Inokuchi.
Jcr-journal of Clinical Rheumatology | 2010
Taku Inokuchi; Zenta Tsutsumi; Sumio Takahashi; Tsuneyoshi Ka; Yuji Moriwaki; Tetsuya Yamamoto
Background:Gout patients are frequently complicated with hypertension, obesity, dyslipidemia, and/or impaired glucose tolerance, which are components of the metabolic syndrome and risks for atherosclerotic diseases. Objectives:To determine the relationship between metabolic syndrome and gout, as well as plasma concentrations of adipocytokines in gout patients. Subjects and Methods:The frequency of metabolic syndrome as well as its constituents were investigated in 258 male gout patients and 111 males who attended an annual check-up examination. In addition, plasma concentrations of adipocytokines were measured in 107 of the patients. Results:Gout patients had a higher prevalence of metabolic syndrome as compared with the controls (36.4% vs. 15.3%, P < 0.0001). In addition, frequencies of individual metabolic abnormalities, such as waist circumference >85 cm, hypertension, and hypertriglyceridemia, were significantly increased in the gout patients as compared with the controls. Furthermore, uric acid over-production gout had a significantly higher prevalence of metabolic syndrome as compared with uric acid under-excretion gout (48.6% vs. 32.4%, P < 0.001). The plasma concentrations of leptin and plasminogen activator inhibitor-1 were significantly higher in the patients (P < 0.05, respectively), while that of adiponectin and the adiponectin/leptin ratio were significantly decreased in the gout patients as compared with the controls (P < 0.05, respectively). Conclusion:A higher prevalence of metabolic syndrome in gout patients may in part contribute to susceptibility to atherosclerotic diseases. Therefore, more attention should be paid to the presence of metabolic syndrome in gout patients to reduce their risk for cardiovascular disease complications.
Cytokine | 2008
Taku Inokuchi; Tuneyoshi Ka; Asako Yamamoto; Yuji Moriwaki; Sumio Takahashi; Zenta Tsutsumi; Daisuke Tamada; Tetsuya Yamamoto
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Image duplication has been observed within Figure 3. The corresponding author has been asked to provide an acceptable explanation for this duplication but has not been able to do so, neither have the original source files been supplied.
Nucleosides, Nucleotides & Nucleic Acids | 2010
Tetsuya Yamamoto; Taku Inokuchi; Tuneyoshi Ka; Asako Yamamoto; Sumio Takahashi; Zenta Tsutsumi; Daisuke Tamada; Chiharu Okuda; Yuji Moriwaki
Objective: It has been demonstrated that uridine infusion induces insulin resistance in rats. Furthermore, it was recently reported that plasma uridine is correlated with homeostasis model assessment of insulin resistance (HOMA-R) in hypertensive patients. Therefore, we investigated whether plasma uridine was correlated with HOMA-R in patients with non-insulin-dependent diabetes mellitus (NIDDM). Subjects and Methods: The subjects were 23 male patients with NIDDM (average age 63 years) and 18 healthy males (average age 60 years). Blood samples were drawn after an overnight fast, plasma uridine was then measured using high-performance liquid chromatography. Results: The average plasma uridine concentration in patients with NIDDM was higher than that in healthy subjects (P < 0.05). Furthermore, plasma uridine values were positively correlated with HOMA-R (r = 0.48, P < 0.05), serum insulin (r = 0.46, P < 0.05), and serum C-peptide radioimmunoreactivity (CPR) (r = 0.44, P < 0.05) values, whereas they were not significantly correlated with fasting blood glucose or hemoglobin A1c values. Conclusion: We found a positive relationship between plasma uridine value and HOMA-R, serum insulin, and CPR, suggesting that plasma uridine is a marker of insulin resistance in patients with NIDDM.
Nucleosides, Nucleotides & Nucleic Acids | 2008
Taku Inokuchi; Tuneyoshi Ka; Asako Yamamoto; Sumio Takahashi; Zenta Tsutsumi; Yuji Moriwaki; Tetsuya Yamamoto
We investigated the effects of allopurinol on beer-induced changes in the plasma concentration and urinary excretion of purine bases. Five healthy subjects underwent three studies: ingestion of beer after taking 300 mg allopurinol (combination study); ingestion of beer alone; ingestion of allopurinol alone. Increased plasma concentrations and urinary excretion of hypoxanthine were greater in the combination study than the beer alone study. However, increases in total plasma purine base concentrations were greater in the beer alone study, even though increases in plasma uridine concentrations did not differ. Beer-induced increases in plasma concentrations of purine bases appear partially offset by increased urinary excretion of hypoxanthine after allopurinol, which also controls increases in plasma uric acid levels caused by alcoholic beverage ingestion.
Metabolism-clinical and Experimental | 2010
Tuneyoshi Ka; Taku Inokuchi; Daisuke Tamada; Michio Suda; Zenta Tsutsumi; Chihiro Okuda; Asako Yamamoto; Sumio Takahashi; Yuji Moriwaki; Tetsuya Yamamoto
To investigate whether the concentration of uridine in plasma is related to the urinary excretion of urea, 45 healthy male subjects with normouricemia and normal blood pressure were studied after providing informed consent. Immediately after collection of 24-hour urine, blood samples were drawn after an overnight fast except for water. The contents of ingested foods during the 24-hour urine collection period were described by the subjects and analyzed by a dietician. Simple regression analysis showed that plasma uridine was correlated with the urinary excretions of urea (R = 0.41, P < .01), uric acid (R = 0.36, P < .05), and uridine (R = 0.30, P < .05), as well as uric acid clearance (R = 0.35, P < .05) and purine intake (R = 0.30, P < .05). In contrast, multiple regression analysis showed a positive relationship only between plasma uridine and urinary excretion of urea. These results suggest that an increase in de novo pyrimidine synthesis leads to an increased concentration of uridine in plasma via nitrogen catabolism in healthy subjects with normouricemia and normal blood pressure.
Nucleosides, Nucleotides & Nucleic Acids | 2008
Yuji Moriwaki; Taku Inokuchi; Tuneyoshi Ka; Asako Yamamoto; Zenta Tsutsumi; Sumio Takahashi; Tetsuya Yamamoto
Sucrose is converted fructose and glucose, which may increase plasma uric acid concentration (pUA) through increased purine degradation and/or decreased uric acid (UA) excretion. To investigate effects of acarbose, an inhibitor of alpha-glucosidase, on the increased pUA from sucrose administration, we measured pUA and urinary UA excretion in 6 healthy subjects before and after administering sucrose, with and without co-administration of acarbose. Sucrose raised pUA by 10% (p < 0.01). However, excretion and fractional clearance of UA were unchanged. Sucrose and acarbose coadministration also increased pUA, but less than did sucrose alone (sucrose: 4.9 to 5.4 mg/dl; sucrose + acarbose, 4.7 to 4.9 mg/dl, p < 0.05) without changes in urinary excretion and fractional clearance of UA. Acarbose appears to attenuate the rise in pUA by sucrose ingestion by inhibiting sucrose absorption.
Acta Diabetologica | 2007
Yuji Moriwaki; Taku Inokuchi; Asako Yamamoto; Tsuneyoshi Ka; Zenta Tsutsumi; Sumio Takahashi; Tetsuya Yamamoto
Magnetic Resonance Imaging | 2006
Taku Inokuchi; Takiuchi H; Yuji Moriwaki; Tuneyoshi Ka; Sumio Takahashi; Zenta Tsutsumi; Hiroki Shima; Seiichi Hirota; Tetsuya Yamamoto
Cytokine | 2006
Taku Inokuchi; Yuji Moriwaki; Hiroko Tsutsui; Asako Yamamoto; Sumio Takahashi; Zenta Tsutsumi; Tuneyoshi Ka; Kenji Nakanishi; Tetsuya Yamamoto
Internal Medicine | 2005
Taku Inokuchi; Yuji Moriwaki; Sumio Takahashi; Zenta Tsutsumi; Tsuneyoshi Ka; Tetsuya Yamamoto